Related Experiment Video

Updated: May 3, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

16.1K

New Approaches to Treating Cardiac Cachexia in the Older Patient

Gohar Azhar1, Jeanne Y Wei1

  • 1Reynolds Department of Geriatrics, University of Arkansas for Medical Sciences (UAMS), and Geriatric Research Education and Clinical Center (GRECC), VISN 16, Central Arkansas Veterans Healthcare System (CAVHS), Little Rock, Arkansas, USA.

Current Cardiovascular Risk Reports
|February 4, 2014
PubMed

Insights

Congestive heart failure (CHF) can lead to cardiac cachexia, a serious condition characterized by unintentional weight loss. Early diagnosis and management are crucial to prevent further decline and improve outcomes in elderly patients.

Area of Science:

  • Geriatrics
  • Cardiology
  • Internal Medicine

Background:

  • Congestive heart failure (CHF) is a primary cause of illness and death in older adults, leading to frequent hospitalizations.
  • Advanced CHF can cause serious complications, including cardiac cachexia, defined as over 6% unintentional weight loss in six months.
  • This condition and its progressive weight loss are often missed by patients, families, and healthcare providers, delaying diagnosis and treatment.

Purpose of the Study:

  • To broaden the understanding of cardiac cachexia in advanced congestive heart failure.
  • To identify features aiding in the diagnosis of cardiac cachexia.
  • To inform strategies for minimizing exacerbation, delaying decline, and educating clinicians on management options.

Main Methods:

  • Review of recent research findings on cardiac cachexia in CHF patients.
  • Characterization of diagnostic features.
  • Exploration of potential management strategies.

Main Results:

  • Cardiac cachexia is an overlooked complication of advanced CHF.
  • Delayed diagnosis contributes to further organ tissue loss, weakness, and increased mortality.
  • Research is expanding the understanding of this condition's features and management.

Conclusions:

  • Improved understanding of cardiac cachexia is essential for timely diagnosis and intervention in CHF.
  • Early recognition and management can mitigate progressive decline and improve patient outcomes.
  • Educating clinicians on cardiac cachexia is vital for effective patient care.

Keywords:
catabolic statecongestive heart failurecytokinesdeclineinflammationmuscle wastingsarcopeniaweaknessweight loss

More Related Videos

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

10.8K

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
632
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
481
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
787
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
626
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790